Latest Articles
- Influenza 2010–2011: Lessons from the 2009 pandemic
The 2009 pandemic of influenza A (H1N1) was less severe than some others, thanks in part to advances in diagnosis, treatment, and public health.
- Intracerebral hemorrhage: Pick your poison
Whether to resume anticoagulant therapy after an intracerebral hemorrhage requires careful consideration of many factors, including patient preferences and tolerance of different levels of risk.
- When ‘blue babies’ grow up: What you need to know about tetralogy of Fallot
Children born with tetralogy of Fallot and other congenital heart defects are living longer—long enough, eventually, to present to your clinic.
- What’s new in treating older adults?
Recent studies and trials regarding bone loss, dialysis outcomes, dementia, and other topics.
- Preventing clots: Don’t let the complex overshadow the simple
Although we often approach anticoagulation therapy with a confidence born of familiarity, it is not for the faint of heart.
Approach to a low TSH level: Patience is a virtueConfronted with a low TSH level, physicians should not jump to the conclusion that it is due to a hyperthyroid state.
- How to prevent glucocorticoid-induced osteoporosis (August 2010)
Readers comment on preventing glucocorticoid-induced osteoporosis (August 2010) and on electronic medical records (July 2010).
- Should healthy people take a multivitamin?
No. There is no scientific basis for recommending vitamin-mineral supplements to the healthy population.
- Bringing home the ‘medical home’ for older adults
We may be able to improve the care of our vulnerable older patients—and control costs—by taking their primary care to their own homes.